Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
70.03
+1.83 (2.68%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $84 | Buy | Maintains | $84 | +19.95% | Oct 12, 2026 |
| Barclays | Barclays | Buy Reiterates $110 | Buy | Reiterates | $110 | +57.08% | Oct 9, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 | Buy | Maintains | $100 | +42.80% | Oct 2, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $116 | Buy | Initiates | $116 | +65.64% | Sep 24, 2026 |
| Jefferies | Jefferies | Buy Reiterates $105 | Buy | Reiterates | $105 | +49.94% | Sep 8, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $100 | Buy | Maintains | $100 | +42.80% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $104 | Buy | Reiterates | $104 | +48.51% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.